Court Finds Patent Office's Rejection Lacked Adequate Reasoning and Directs Re-evaluation by a Different Officer
In a significant ruling, the Madras High Court has set aside the rejection of a patent application filed by Elanco Us Inc, a prominent player in the pharmaceutical industry, regarding an oral pharmaceutical composition for treating chronic inappetence and weight loss in companion animals. The court found that the rejection by the Assistant Controller of Patents and Designs was arbitrary, lacking sufficient reasoning, and has directed a reconsideration by a different officer to ensure fairness and avoid pre-determination.
The judgment, delivered by Justice K. Kumaresh Babu, centered around the rejection of Elanco's patent application due to an alleged lack of an inventive step under Section 2(1)(ja) of the Patents Act, 1920. The Assistant Controller had based the rejection on prior art D1, asserting that the claimed invention was substantially similar to prior disclosures. However, the court noted that the invention differed from the prior art by providing safety data and demonstrating the absence of adverse clinical side effects, which were not addressed in the prior art.
Justice Babu emphasized that the reasoning given by the patent office was inconsistent, as it acknowledged differences from prior art but still rejected the application for lack of an inventive step. The court deemed this approach arbitrary and lacking in adequate reasoning, warranting a re-evaluation.
The court has directed that the reconsideration be conducted by an officer other than the one who issued the original rejection, to preclude the possibility of pre-determination. Furthermore, the court has instructed that Elanco Us Inc be given a reasonable opportunity to present their case, and a well-reasoned decision be issued within four months from the receipt of the court's order.
This decision highlights the judiciary's role in ensuring transparency and fairness in the patent application process, particularly in cases where the rejection appears to lack substantive reasoning. The outcome of the reconsideration could have significant implications for the pharmaceutical industry, especially for innovations in veterinary medicine.
Bottom line:-
Patent Law - Rejection of patent application due to alleged lack of inventive step under Section 2(1)(ja) of the Patents Act, 1920 found arbitrary - Matter directed for reconsideration by a different officer to ensure fairness and avoid pre-determination.
Statutory provision(s): Patents Act, 1920 Section 2(1)(ja)
Elanco Us Inc v. Assistant Controller of Patents and Designs, (Madras) : Law Finder Doc id # 2944669
